Non-pharmacological management strategies for type 2 diabetes in children and young adults: A systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39961515/
Evidence for non-pharmacological management of youth onset type 2 diabetes is scarce. Available evidence demonstrated that VLED is associated with improved glycemia and weight loss. The role of social support...
This systematic review found limited evidence for non-pharmacological management of youth-onset type 2 diabetes, with very low-energy diets improving HbA1c and weight, while other interventions showed mixed effects on glycemia and well-being.
Key biomarkers in type 2 diabetes patients: A systematic review - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39355932/
Type 2 diabetes mellitus (T2DM) is not just a local health issue but a significant global health burden, affecting patient outcomes and clinical management worldwide. Despite the wealth of studies...
This review analyzes T2DM biomarkers in haematological, protein, cytokine, and lipid profiles, highlighting inflammation, altered cell counts, and dyslipidemia, providing insights for innovative diagnostic and prognostic diabetes management strategies.
Tirzepatide for overweight and obesity management - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39632534/
Tirzepatide marks a new era in overweight/obesity treatment, enabling many to achieve ≥ 20% weight loss. It is well-tolerated with a safety profile similar to GLP-1 receptor agonists. Tirzepatide also...
Tirzepatide, a dual GLP-1/GIP agonist, enables ≥20% weight loss with improved obesity-related complications. The SURMOUNT program highlights its efficacy, safety, and potential in obesity and type 2 diabetes management.
Schizophrenia and type 2 diabetes risk: a systematic review and meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39324122/
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023465826.
This meta-analysis of 32 studies finds a significant association between schizophrenia and increased risk of type 2 diabetes (T2DM), with higher risks observed in females, certain regions, and longer follow-up periods.
Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38854688/
Muscle loss is a significant health concern, particularly with the increasing trend of population aging, and sarcopenia has emerged as a common pathological process of muscle loss in the elderly....
This review highlights the differences between sarcopenia, disuse muscle atrophy, and Type 2 Diabetes Mellitus (T2DM)-related sarcopenia, emphasizing the need for further research to improve diagnosis and treatment strategies.